[Federal Register Volume 73, Number 202 (Friday, October 17, 2008)]
[Notices]
[Page 61912]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-24777]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 28, 2008, and published in the Federal 
Register on May 2, 2008, (73 FR 24313), Abbott Laboratories, DBA Knoll 
Pharmaceutical Company, 30 North Jefferson Road, Whippany, New Jersey 
07981, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
 Dihydromorphine (9145)....................   I
 Hydromorphone (9150)......................   II
------------------------------------------------------------------------

    The company plans to manufacture bulk product and dosage units for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Abbott Laboratories to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Abbott Laboratories to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: October 9, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-24777 Filed 10-16-08; 8:45 am]
BILLING CODE 4410-09-P